Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects (AFF012)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02508896 |
|
Recruitment Status :
Completed
First Posted : July 27, 2015
Last Update Posted : October 20, 2017
|
Sponsor:
Affiris AG
Collaborator:
Medical University of Vienna
Information provided by (Responsible Party):
Affiris AG
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 2016 |
| Actual Study Completion Date : | August 31, 2017 |